Pharmacy Times

NOVEMBER 3, 2023

It is crucial to continue to evolve from dependent prescribing to an independent model, and address barriers with opportunities for change.

158

158

STAT

NOVEMBER 3, 2023

More than 10 million people were disenrolled from Medicaid over the past six months, according to the latest data published by a KFF tracker. The tracker has collected data on Medicaid enrollment since the first states began redetermining eligibility in April, after the expiration of the federal requirement of continuous coverage during the Covid-19 public health emergency.

Insurance 144

Insurance 144

Pharmacy Times

NOVEMBER 3, 2023

Coca notes the importance of precision medicine in CKD risk assessment and describes the potential impact multiple therapies can have on future CKD prediction and treatment in the future.

136

136

Fierce Pharma

NOVEMBER 3, 2023

Pfizer’s plunging COVID-19 product demand has spurred a companywide cost-cutting campaign, with nearly 200 jobs now on the chopping block in Michigan. | Pfizer is cutting roughly 200 positions at its Kalamazoo site following a review of demand for its COVID-19 vaccine and antiviral Comirnaty and Paxlovid.

Vaccines 141

Vaccines 141

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

NOVEMBER 3, 2023

In most patients who are pregnant or may become pregnant, warfarin is contraindicated due to increased risk of adverse fetal outcomes.

156

156

STAT

NOVEMBER 3, 2023

’Tis the season — open enrollment season, that is. Since before the Nov. 1  start to the annual open enrollment period, the advertising engines for state health insurance marketplaces, and the federal exchange,  healthcare.gov , have been revving up. The nation’s uninsurance rate is down to  7.7% — the lowest it has ever been.

Insurance 137

Insurance Documentation Hospitals 137

STAT

NOVEMBER 3, 2023

I was living on the precipice of end-stage disease when I enrolled in the clinical trial that resulted in the historically fast Food and Drug Administration approval for the game-changing cystic fibrosis drug Trikafta. Five years later, the worst parts of my CF are gone. I recently recovered from a viral infection that provoked a pneumonia-like illness without landing in a hospital tied to an oxygen tank.

Hospitals 137

Hospitals 137

Drug Topics

NOVEMBER 3, 2023

Attendees at an AMCP Nexus session received an overview of FDA approvals granted in 2023 as well as a preview of nononcology drugs to be released over the next 5 years.

FDA 112

FDA 112

Pharmacy Times

NOVEMBER 3, 2023

On this month's episode, Pharmacy Times covers the Academy of Managed Care Pharmacy Nexus 2023 conference, highlighting the updates on biosimilars.

132

132

STAT

NOVEMBER 3, 2023

How old is Claire Snyman? “I am now…” she says with pause. “I always have to think. I have a brain injury as a result of my surgery, so many of these things do not come naturally to me.” The thought arrives. She is 47. But on this day in late August, there’s a more important anniversary: 11 years since doctors removed an expanding mass from her brain.

126

126

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

NOVEMBER 3, 2023

Pneumococcal serotype 3 was prevalent regardless of vaccination status, with the most common cases being in those with chronic lung disease.

Vaccines 138

Vaccines 138

Drug Topics

NOVEMBER 3, 2023

Speakers at an AMCP Nexus session provided an in-depth understanding of how changes brought on by the Inflation Reduction Act (IRA) have impacted Medicare, as well as what provisions are to come.

98

98

STAT

NOVEMBER 3, 2023

The federal government is moving forward with a spate of proposals that will force hospitals to be better about publishing the prices they charge health insurers and patients. Federal law has required hospitals to post their prices since 2021. Compliance has been dismal , although it has improved since the government increased fines a few years ago.

Hospitals 120

Hospitals Insurance 120

Drug Topics

NOVEMBER 3, 2023

By way of natural immunity, vaccination, and behavior change, the majority of the 30,861 documented cases and 54 deaths were confined to 2022, and the epidemic curve portrays a picture of success.

Documentation 98

Documentation Immunization Vaccines 98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Healthcare

NOVEMBER 3, 2023

Insurance policies are notoriously known for red tape and processes that burden both doctors and patients. | The time-sensitive GI procedures that UHC is targeting with prior authorization are critical in helping to detect, treat, and monitor a range of diseases that impact millions of Americans.

Patient Care 117

Patient Care Insurance 117

The Checkup by Singlecare

NOVEMBER 3, 2023

“If you keep eating like that, you’re going to get diabetes.” If you’ve ever been scolded like this for enjoying a sugar-laden dessert, know that an occasional confection isn’t going to send you immediately into poor health. However, it is important to understand the consequences of the nutritional choices that you make, such as a diet that includes excessive amounts of added sugar.

Labelling 116

Labelling Packaging Immunization 116

Fierce Pharma

NOVEMBER 3, 2023

Bausch Health’s gastroenterology unit Salix Pharmaceuticals has chalked up a win in its long-running fight to fend off a generic to its irritable bowel syndrome diarrhea (IBD-D) med Xifaxan. | The D.C. federal court denied Alvogen's bid to force the FDA to grant full approval to its proposed Xifaxan generic. The agency previously gave the generic a tentative approval before some patents expire in 2029.

FDA 114

FDA 114

Fierce Healthcare

NOVEMBER 3, 2023

Among a rush of new changes in 2024, Independence Blue Cross is introducing new health plans, increased access to virtual care and in-network dental plans. | Independence Blue Cross is prioritizing three new health plans and virtual care as part its batch of offerings heading into 2024.

113

113

Drug Topics

NOVEMBER 3, 2023

During a session at AMCP Nexus, presenters discussed the delicate balance between cost and innovation as it relates to forthcoming oncology treatments.

98

98

Fierce Healthcare

NOVEMBER 3, 2023

Innovation is often measured and marked by disruption – particularly in healthcare. | Innovation is often measured and marked by disruption – particularly in healthcare.

115

115

STAT

NOVEMBER 3, 2023

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. There’s potential that a stem cell infusion from kidney donors might help prevent organ rejection — allowing patients to perhaps wean from immunosuppressive drugs. We see the Senate is getting serious about PBMs, and have a neat podcast, as always.

Vaccines 111

Vaccines Insurance FDA 111

Fierce Pharma

NOVEMBER 3, 2023

In its attempt to win approval in the United States for its groundbreaking T-cell therapy Ebvallo (tabelecleucel), Atara Biotherapeutics is turning to the same partner it used to gain a green light | In its attempt to win approval in the United States for its groundbreaking T-cell therapy Ebvallo, Atara Biotherapeutics is turning to the same partner it used to gain a green light in Europe—Pierre Fabre Laboratories.

109

109

STAT

NOVEMBER 3, 2023

Most of the formularies run by some of the largest health plans in the U.S. generally provide “fair access” to 18 treatments for a handful of serious diseases, although transparent coverage information is often lacking for some medicines, a new analysis has found. Almost uniformly, the 19 formularies made the medicines available fairly when judged on three criteria: eligibility based on clinical data, restrictions placed on prescribers, and step therapy, which requires patients to

Department of Veterans Affairs 110

Department of Veterans Affairs Insurance 110

Drug Store News

NOVEMBER 3, 2023

John Driscoll, executive vice president and president of U.S. healthcare at Walgreens Boots Alliance, discusses the company’s vision for the future of health care.

111

111

Drug Topics

NOVEMBER 3, 2023

Ravi Patel, PharmD, MBA, MS, discusses how artificial intelligence can be a benefit to both patients and community pharmacies.

Community Pharmacies 98

Community Pharmacies 98

Pharmacy Times

NOVEMBER 3, 2023

Nephrotoxic care can be improved with better risk score assessment and provider education.

132

132

PharmExec

NOVEMBER 3, 2023

Due to a global demand, treatments such as Adderall and Ritalin have been in short supply for the management of attention-deficit hyperactivity disorder.

105

105

The Thyroid Pharmacist

NOVEMBER 3, 2023

Got reflux? I had reflux, too. It started with a chronic cough, pain, burning, and choking sensation. I tried every over-the-counter product possible. I saw my primary care doctor, an allergist, a gastroenterologist, and an ear, nose, and throat doctor. I even had a barium swallow test where I swallowed a nasty, chalky substance, and the test revealed I had a sliding hiatal hernia with spontaneous reflux.

Immunization 94

Immunization Dosage Mayo Clinic Compounding 94

Drug Store News

NOVEMBER 3, 2023

Since the program's inception in 2021, more than $10 million have gone to nonprofits—all chosen by Meijer team members across the Midwest.

105

105

European Pharmaceutical Review

NOVEMBER 3, 2023

The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Pfizer’s Litfulo (ritlecitinib) for treatment for severe alopecia areata in patients 12 years and older. A hard capsule medicine, Litfulo is recommended to be taken daily as one 50mg oral dose. Litfulo’s active ingredient, ritlecitinib, is an enzyme inhibitor. It works irreversibly and selectively inhibits Janus kinase 3 (JAK3) and the tyrosine (TEC) family of kinases by blocking γ-common cytokine signalling and reduc

Immunization 92

Immunization FDA 92

Drug Store News

NOVEMBER 3, 2023

Nov. 10–13, veterans, military and their families will receive 20% off regular price eligible store items at any Walgreens or Duane Reade drug store nationwide.

98

98

STAT

NOVEMBER 3, 2023

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. Please note that our regular feature — in which we spotlight someone — will return next week.

91

91

Outsourcing Pharma

NOVEMBER 3, 2023

From Disney to the drug world, Liss Easy has had a fascinating journey to where she is now in her role as vice president and general manager of clinical operations at IQVIA.

86

86

STAT

NOVEMBER 3, 2023

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda, so far, is exceedingly modest. We will attempt to employ a new device for moving leaves about the official grounds, catch up on our reading and perhaps hold another listening party.

Packaging 87

Packaging Insurance 87